(Q35075798)

6 August 2017

1 reference

title

New migraine preventive options: an update with pathophysiological considerations (English)

1 reference

6 August 2017

1 reference

1 reference

1

Marcelo E Bigal

1 reference

6 August 2017

4

Stewart J Tepper

1 reference

6 August 2017

Alan M Rapoport

2

1 reference

6 August 2017

Fred D Sheftell

series ordinal

3

1 reference

6 August 2017

publication date

1 November 2002

1 reference

Revista do Hospital das Clinicas

6 August 2017

published in

1 reference

6 August 2017

volume

57

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

293-298

1 reference

Pathophysiology of the migraine aura. The spreading depression theory

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Mitochondria, magnesium and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Magnesium deficiency and excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0041-87812002000600009

10.1590/S0041-87812002000600009

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference